Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Pimitespib by Otsuka Pharmaceutical for Endometrial Cancer: Likelihood of Approval
Pimitespib is under clinical development by Otsuka Pharmaceutical and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase...
Pimitespib by Otsuka Pharmaceutical for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
Pimitespib is under clinical development by Otsuka Pharmaceutical and currently in Phase I for Human Epidermal Growth Factor Receptor 2...
Pimitespib by Otsuka Pharmaceutical for Bladder Cancer: Likelihood of Approval
Pimitespib is under clinical development by Otsuka Pharmaceutical and currently in Phase I for Bladder Cancer. According to GlobalData, Phase...
Pimitespib by Otsuka Pharmaceutical for Small-Cell Lung Cancer: Likelihood of Approval
Pimitespib is under clinical development by Otsuka Pharmaceutical and currently in Phase I for Small-Cell Lung Cancer. According to GlobalData,...